The haul brings League's total funding to more than $205 million. The Series C funding round was led by TDM Growth Partners with Workday Ventures and other unnamed existing investors also participating.
We are extending our INVEST 2022 Pitch Perfect deadline to Feb 11, 11:59 p.m. ET to allow interested startups to apply to the 4 tracks - PharmaTech, Diagnostics 2.0, Care Coordination and Value-Based Care, and Remote Patient Monitoring and Smart Devices. Slots are going fast so we encourage all startups - particularly those interested to apply in the PharmaTech and Diagnostics tracks to apply immediately. Selected startups will get to pitch LIVE on stage in front of VC judges. Here's the agenda for the INVEST conference.
UBC partners with Seqster to leverage the latter's technology to allow patients to gather their own medical records for decentralized clinical trials. This could help speed up clinical trial enrollment.
By Arundhati Parmar Thursday, February 3, 2022 12:37 AM
Formus Labs is expecting to get the regulatory nod from the FDA to be able to sell its fully-automated 3D planning technology for joint replacement surgeries in the second quarter and has partnered with orthopedic surgery heavyweight for a global distribution program.
By Michael Schroeder Wednesday, February 2, 2022 7:35 PM
Funding for 2021 was up 150% from the previous record of $3.6 billion raised in 2020, according to the 2022 New York Healthcare Innovation Report. Digital health startups in areas including virtual care, patient engagement and mental health captured 87% of funds.
By Stephanie Baum Wednesday, February 2, 2022 6:04 PM
Register for MedCity INVEST at the Ritz Carlton in Chicago and be part of the conversation on healthcare investment trends. Attendees will also be able to take part in networking opportunities and hear health tech, medtech and pharma tech startups pitch to investors.
By Michael Schroeder Wednesday, February 2, 2022 1:03 PM
Shkreli controversially raised the price of the drug Daraprim, which is used to treat a potentially fatal parasitic infection, by 4,000%, from $13.50 to $750 per pill in 2015. In January, a federal judge banned him from the pharmaceutical industry for life.
By Bernadette M. Broccolo and Michael W. Peregrine Wednesday, February 2, 2022 8:30 AM
The power and promise of artificial intelligence comes in a Pandora's box full of novel and multi-dimensional enterprise risks—legal, regulatory, financial, operational, ethical and reputational—that go above and beyond those associated with other technology innovations.
No comments